Stock Market Nation desk

Food & Health

Food, healthcare, biotechnology, wellness, and consumer health markets.

19 stories

Analysis

Merck's $1.3B Acquisition of Silence Therapeutics

Explore Merck's bold $1.3B move for Silence Therapeutics at a premium, expanding its RNA-silencing pipeline and impacting biotech valuations.

Food & Health

AstraZeneca Targets AI with $1.5B Insitro Deal

Explore how AstraZeneca's $1.5B collaboration with Insitro alters the pharma landscape, focusing on AI-driven drug discovery milestones.

Oct 164 min read

Food & Health

Kroger's Job Cuts: AI Reshape for Investors

Oct 153 min read

Food & Health

GSK's $800M Deal: Biologics Boost in PA

Oct 153 min read

Food & Health

AstraZeneca's Bold $1B Move in Massachusetts

Oct 83 min read

Food & Health

Juvmo Approval Activates AbbVie's $5B Parkinson's Plan

Sep 283 min read

Latest Food & Health

Food & Health

Roche's Enicepatide Boosts Competitiveness

Roche's Enicepatide triumphs in trials, affecting deal terms and valuations against GLP-1 leaders.

Sep 223 min read

Food & Health

Pfizer's Legal Tactics in $2B Vaccine Dispute

Pfizer targets air-traffic fees to reclaim $2B, spotlighting contract risks and sector implications.

Sep 143 min read

Food & Health

Pipeline Pressures Challenge Novartis Post Avidity Deal

Novartis's Avidity acquisition faces scrutiny after neuromuscular drug trial misses key goals. Explore the implications on deal valuation.

Sep 83 min read

Food & Health

Ionis Gains FDA Nod on Zanvastro for Rare Disease

FDA approval of Zanvastro may impact rare disease market valuation. Explore deal terms and sector implications for Ionis.

Sep 44 min read

Food & Health

Nestlé's $393M Boost Targets Brazil Formula

Nestlé invests $393M in Brazil, focusing on infant formula production to replace imports. Strategic move highlights sector growth.

Sep 33 min read

Food & Health

Tyson's Plant Sales Invite Global Buyers, Risk Looms

Tyson's plant sales invite global offers, countering USDA, affecting deal terms and valuation in beef sector.

Sep 24 min read

Food & Health

Novartis Halts CAR-T Trials Amid Fatal Risks

Explore the valuation impact after Novartis paused CAR-T trials due to patient deaths. Sector-wide safety concerns rise.

Sep 13 min read

Food & Health

Trump's 90-Day Beef Tariff Lift: Implications for JBS

Explore deal terms and sector implications as JBS gains from Trump's tariff rollback, impacting U.S. beef market competition.

Sep 13 min read

Food & Health

Imaavy's FDA Approval: Pharma Valuation Impact

J&J's Imaavy gets FDA nod for wAIHA, reshaping deal terms and revenue paths in rare-disease pharma.

Aug 253 min read

Food & Health

Regenxbio Shares Plunge Amid Clinical Hold Setback

RGX-121 trial halt impacts Regenxbio's valuation, highlighting sector risks with spinal nodules discovery.

Aug 243 min read

Food & Health

$245M Verdict Deals Guardant Financial Blow

Patent ruling forces costly royalties on Guardant, affecting its market growth and revenue projections significantly.

Aug 243 min read

Food & Health

Pasatru Gets FDA OK, Boosts Regeneron by 4%

Regeneron climbs 4% with Pasatru's FDA nod, enhancing its foothold in orphan-drug market with premium pricing potential.

Aug 203 min read

Food & Health

JBS Pursues Pilgrim's Pride Minority Buyout

Explore JBS's offer for remaining Pilgrim's Pride shares, focusing on deal terms and valuation impact on investors.

Aug 193 min read